News | December 20, 2023
Venus Remedies' R3SET forays into wellness
The launch of R3SET Detox Candies positions the brand at the forefront of the wellness journey
The launch of R3SET Detox Candies positions the brand at the forefront of the wellness journey
Trastuzumab deruxtecan (Enhertu) is indicated for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer
10+ emerging markets, Japan & ANZ transition in final phase
Receives registration of Valganciclovir powder for oral solution in Germany
Expansion of presence in India with electrical safety, electromagnetic compatibility and medical device biocompatibility, toxicity and microbiology testing and certification services
Leading USA based genetic testing brand officially enters the Indian market
The CVMP recommends the product for approval for the treatment and persistent killing of fleas
Late-stage Fabhalta development program ongoing in multiple complement-mediated conditions
Methylene blue is a cationic thiazine dye that necessitates specialised capabilities and expertise to develop and manufacture the product
The current annual U.S. market for Sildenafil for Oral Suspension is approximately $43 million
Subscribe To Our Newsletter & Stay Updated
